Krell-Roesch J, Syrjanen JA, Vassilaki M, Lowe VJ, Vemuri P, Mielke MM, et al. Brain regional glucose metabolism, neuropsychiatric symptoms, and the risk of incident mild cognitive impairment: the mayo clinic study of aging. Am J Geriatr Psychiatry. 2021;29:179–91.

Article  PubMed  Google Scholar 

Hwang TJ, Masterman DL, Ortiz F, Fairbanks LA, Cummings JL. Mild cognitive impairment is associated with characteristic neuropsychiatric symptoms. Alzheimer Dis Assoc Disord. 2004;18:17–21.

Article  PubMed  Google Scholar 

Chaudhary S, Zhornitsky S, Chao HH, van Dyck CH, Li CR. Emotion processing dysfunction in Alzheimer’s disease: an overview of behavioral findings, systems neural correlates, and underlying neural biology. Am J Alzheimers Dis Other Demen. 2022;37:15333175221082834.

Article  PubMed  PubMed Central  Google Scholar 

Kim J, Fischer CE, Schweizer TA, Munoz DG. Gender and pathology-specific effect of Apolipoprotein E genotype on psychosis in Alzheimer’s disease. Curr Alzheimer Res. 2017;14:834–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Holland D, Desikan RS, Dale AM, McEvoy LK, Alzheimer’s Disease Neuroimaging I. Higher rates of decline for women and apolipoprotein E epsilon4 carriers. AJNR Am J Neuroradiol. 2013;34:2287–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hollingworth P, Hamshere ML, Moskvina V, Dowzell K, Moore PJ, Foy C, et al. Four components describe behavioral symptoms in 1120 individuals with late-onset Alzheimer’s disease. J Am Geriatr Soc. 2006;54:1348–54.

Article  PubMed  Google Scholar 

Eikelboom WS, Pan M, Ossenkoppele R, Coesmans M, Gatchel JR, Ismail Z, et al. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis. Alzheimers Res Ther. 2022;14:48.

Article  PubMed  PubMed Central  Google Scholar 

Hirata-Fukae C, Li HF, Hoe HS, Gray AJ, Minami SS, Hamada K, et al. Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model. Brain Res. 2008;1216:92–103.

Article  CAS  PubMed  Google Scholar 

Melnikova T, Park D, Becker L, Lee D, Cho E, Sayyida N, et al. Sex-related dimorphism in dentate gyrus atrophy and behavioral phenotypes in an inducible tTa:APPsi transgenic model of Alzheimer’s disease. Neurobiol Dis. 2016;96:171–85.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schmid S, Rammes G, Blobner M, Kellermann K, Bratke S, Fendl D, et al. Cognitive decline in Tg2576 mice shows sex-specific differences and correlates with cerebral amyloid-β. Behav Brain Res. 2019;359:408–17.

Article  CAS  PubMed  Google Scholar 

Bories C, Guitton MJ, Julien C, Tremblay C, Vandal M, Msaid M, et al. Sex-dependent alterations in social behaviour and cortical synaptic activity coincide at different ages in a model of Alzheimer’s disease. PLoS One. 2012;7:e46111.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arsenault D, Tremblay C, Emond V, Calon F. Sex-dependent alterations in the physiology of entorhinal cortex neurons in old heterozygous 3xTg-AD mice. Biol Sex Differ. 2020;11:63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pairojana T, Phasuk S, Suresh P, Huang SP, Pakaprot N, Chompoopong S, et al. Age and gender differences for the behavioral phenotypes of 3xTg Alzheimer’s disease mice. Brain Res. 2021;1762:147437.

Article  CAS  PubMed  Google Scholar 

Sun Y, Guo Y, Feng X, Jia M, Ai N, Dong Y, et al. The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer’s disease. J Neuroinflammation. 2020;17:72.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferretti MT, Iulita MF, Cavedo E, Chiesa PA, Schumacher Dimech A, Santuccione Chadha A, et al. Sex differences in Alzheimer disease - the gateway to precision medicine. Nat Rev Neurol. 2018;14:457–69.

Article  PubMed  Google Scholar 

Düzel E, Ziegler G, Berron D, Maass A, Schutze H, Cardenas-Blanco A, et al. Amyloid pathology but not APOE ε4 status is permissive for tau-related hippocampal dysfunction. Brain. 2022;145:1473–85.

Article  PubMed  PubMed Central  Google Scholar 

Sperling RA, Mormino EC, Schultz AP, Betensky RA, Papp KV, Amariglio RE, et al. The impact of amyloid-β and tau on prospective cognitive decline in older individuals. Ann Neurol. 2019;85:181–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harrison TM, Maass A, Adams JN, Du R, Baker SL, Jagust WJ. Tau deposition is associated with functional isolation of the hippocampus in aging. Nat Commun. 2019;10:4900.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereira JB, Janelidze S, Ossenkoppele R, Kvartsberg H, Brinkmalm A, Mattsson-Carlgren N, et al. Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer’s disease. Brain. 2021;144:310–24.

Article  PubMed  Google Scholar 

Guo T, Korman D, Baker SL, Landau SM, Jagust WJ, Alzheimer’s Disease Neuroimaging I. Longitudinal cognitive and biomarker measurements support a unidirectional pathway in Alzheimer’s disease pathophysiology. Biol Psychiatry. 2021;89:786–94.

Article  CAS  PubMed  Google Scholar 

Pascoal TA, Mathotaarachchi S, Mohades S, Benedet AL, Chung CO, Shin M, et al. Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer’s disease. Mol Psychiatry. 2017;22:306–11.

Article  CAS  PubMed  Google Scholar 

Yu M, Risacher SL, Nho KT, Wen Q, Oblak AL, Unverzagt FW, et al. Spatial transcriptomic patterns underlying amyloid-beta and tau pathology are associated with cognitive dysfunction in Alzheimer’s disease. Cell Rep. 2024;43:113691.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kim CM, Diez I, Bueicheku E, Ahn S, Montal V, Sepulcre J. Spatiotemporal correlation between amyloid and tau accumulations underlies cognitive changes in aging. J Neurosci. 2024;44:e0488232023.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Grueninger F, Bohrmann B, Czech C, Ballard TM, Frey JR, Weidensteiner C, et al. Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice. Neurobiol Dis. 2010;37:294–306.

Article  CAS  PubMed  Google Scholar 

Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Aβ42 fibrils. Science. 2001;293:1491–5.

Article  CAS  PubMed  Google Scholar 

Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science. 2001;293:1487–91.

Article  CAS  PubMed  Google Scholar 

He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-β plaques enhance Alzheimer’s brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation. Nat Med. 2018;24:29–38.

Article  CAS  PubMed  Google Scholar 

Bennett RE, DeVos SL, Dujardin S, Corjuc B, Gor R, Gonzalez J, et al. Enhanced tau aggregation in the presence of amyloid-β. Am J Pathol. 2017;187:1601–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, et al. Reducing endogenous tau ameliorates amyloid β-induced deficits in an Alzheimer’s disease mouse model. Science. 2007;316:750–4.

Article  CAS  PubMed